Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
ST-elevation Myocardial Infarction (STEMI)
100%
Myocardial Infarction Patients
71%
Acute Kidney Injury
59%
Primary Percutaneous Coronary Intervention
39%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
19%
Percutaneous Coronary Intervention
17%
Percutaneous Intervention
16%
Long-term Mortality
16%
Transcatheter Aortic Valve Implantation
14%
C-reactive Protein
12%
Acute Myocardial Infarction
9%
Primary Coronary Intervention
9%
Serum Creatinine
8%
Prognostic Implications
8%
Confidence Interval
8%
Renal Impairment
7%
Left Ventricular Function
7%
Left Ventricular Ejection Fraction
7%
Left Ventricular Thrombus
6%
Echocardiography
6%
Cardiorenal Syndrome
6%
Consecutive Patients
6%
All-cause Mortality
5%
30-day Mortality
5%
C-reactive Protein Level
5%
In-hospital Complications
5%
Hospitalization
5%
Contrast-induced Nephropathy
5%
Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
72%
Acute Kidney Injury
44%
Primary Percutaneous Coronary Intervention
34%
Myocardial Infarction
28%
Percutaneous Coronary Intervention
15%
Neutrophil Gelatinase Associated Lipocalin
15%
C Reactive Protein
13%
Percutaneous Aortic Valve Replacement
13%
Percutaneous Intervention
12%
Echocardiography
9%
Creatinine
8%
Heart Left Ventricle Function
8%
Acute Heart Infarction
8%
Heart Left Ventricle Ejection Fraction
7%
Prevalence
7%
Chronic Kidney Disease
6%
Cardiorenal Syndrome
6%
All Cause Mortality
6%
Observational Study
6%
Thrombus
6%
Ejection Fraction
5%
Kidney Function
5%
ST Elevation
5%
Biological Marker
5%
Adverse Outcome
5%
Odds Ratio
5%
